Efficacy and Safety of Intravenous Thrombolysis in the Extended Time Window for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis

Эффективность и безопасность внутривенного тромболизиса в расширенном временно́м окне при остром ишемическом инсульте: систематический обзор и метаанализ
Effie Polyzogopoulou, Panayiotis D. Mitsias, Georgios K. Tsivgoulis, Jobst Rudolf, Lina Palaiodimou, Aikaterini Theodorou, Apostolοs Safouris, Nikolaos M. Papageorgiou, Eleni Bakola, Maria Eleni Chondrogianni, Georgia Papagiannopoulou, Odysseas Kargiotis, Klearchos Psychogios, George Magoufis, Georgios Velonakis, Georgios Magoufis
2025-08-04

acute ischemic strokeextended time windowintravenous thrombolysismodified Rankin Scalesymptomatic intracranial hemorrhage
Background/Objectives: While intravenous thrombolysis (IVT) is the standard treatment for acute ischemic stroke (AIS) within 4.5 h of symptom onset, many patients present beyond this time window. Recent trials suggest that IVT may be both effective and safe in selected patients treated after the standard time window. Methods: We searched MEDLINE, Scopus, and ClinicalTrials.gov for randomized-controlled clinical trials (RCTs) and individual patient-data meta-analyses (IPDMs) of RCTs comparing IVT plus best medical treatment (BMT) to BMT alone in AIS patients who were last-known-well more than 4.5 h earlier. The primary efficacy outcome was a 90-day excellent functional outcome [modified Rankin Scale (mRS)-scores of 0–1]. Secondary efficacy outcomes included good functional outcome (mRS-scores 0–2) and reduced disability (≥1-point reduction across all mRS-strata). The primary safety outcome was symptomatic intracranial hemorrhage (sICH); secondary safety outcomes were any ICH and 3-month all-cause mortality. Subgroup analyses were performed stratified by different thrombolytics, time-windows, imaging modalities, and affected circulation. Results: Nine studies were included, comprising 1660 patients in the IVT-group and 1626 patients in the control-group. IVT significantly improved excellent functional outcome (RR = 1.24; 95%CI:1.14–1.34; I2 = 0%) and good functional outcome (RR = 1.18; 95%CI:1.05–1.33; I2 = 70%). IVT was associated with increased odds of reduced disability (common OR = 1.3; 95%CI:1.15–1.46; I2 = 0%) and increased risk of sICH (RR = 2.75; 95%CI:1.49–5.05; I2 = 0%). The rates of any ICH and all-cause mortality were similar between the two groups. No significant subgroup differences were documented. Conclusions: IVT in the extended time window improved functional outcomes without increasing mortality, despite a higher rate of sICH.
1
A systematic review and meta-analysis included nine studies with 1,660 IVT-treated and 1,626 control patients presenting beyond 4.5 hours after stroke onset.
2
Extended-window IVT increased symptomatic intracranial hemorrhage risk (RR 2.75, 95% CI 1.49–5.05), but rates of any intracranial hemorrhage and mortality were similar.
3
Extended-window intravenous thrombolysis significantly improved excellent functional outcome at 90 days (RR 1.24, 95% CI 1.14–1.34).
4
IVT also improved good functional outcome (RR 1.18, 95% CI 1.05–1.33) and overall disability reduction (common OR 1.30, 95% CI 1.15–1.46).
5
No significant subgroup differences were found across thrombolytic agents, treatment windows, imaging modalities, or affected circulation.

Acute ischemic stroke patients treated with intravenous thrombolysis plus best medical treatment beyond the standard 4.5-hour window

The efficacy and safety of extended-window intravenous thrombolysis, including functional outcomes, disability reduction, symptomatic intracranial hemorrhage, and mortality

Publication Details
Publication Date
2025-08-04
Journal
Publisher
ISSN
Cited by
16
Access Type
Author Information
Authors
Effie Polyzogopoulou
Panayiotis D. Mitsias
Georgios K. Tsivgoulis
Jobst Rudolf
Lina Palaiodimou
Aikaterini Theodorou
Apostolοs Safouris
Nikolaos M. Papageorgiou
Eleni Bakola
Maria Eleni Chondrogianni
Georgia Papagiannopoulou
Odysseas Kargiotis
Klearchos Psychogios
George Magoufis
Georgios Velonakis
Georgios Magoufis
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%